[ad_1]
Pfizer plans to file an Emergency Use Clearance (EUA) application with the Food and Drug Administration (FDA) for its coronavirus vaccine on Friday, Health and Human Services Secretary Alex Azar said Thursday. in the White House briefing room.
Azar, speaking to reporters at the White House Coronavirus Task Force’s first briefing since July, noted Moderna will soon follow suit at the FDA for its own vaccine.
“We have designed the world’s largest biopharmaceutical research, development, manufacture, distribution and mobilization in partnership with the Department of Defense and President Trump’s unwavering support is delivering results on this,” Azar said. “We are seeing results. They said it couldn’t be done. (Trump says coronavirus vaccine will be available to “ everyone ” by April – adds “ Only time will tell ” who will be in the WH at that time)
WATCH:
Earlier in the presentation, Dr Anthony Fauci – the task force’s lead immunologist – said that the work of Moderna and Pfizer demonstrates the rapid progress made by government and private companies in advancing vaccine development over the course of of the past year. He added that the efficacy rates of 94% and above for the two vaccines almost match the levels achieved by the measles vaccine.
Vice President Mike Pence, the task force leader, and Operation Warp Speed head of distribution Gen. Gustave Parna, added that a distribution plan has been finalized so business and government can begin to ship doses and associated equipment nationwide within 24 hours of FDA. the granting of an EUA.
“America has never been so prepared to fight this virus,” Pence said in conclusion. “We’re all in this. As I’ve said many times from that podium, I know that with the cooperation of the American people and our doctors, nurses and first responders, the extraordinary partnership between federal health authorities, state and local and with God’s help, we will achieve this.
[ad_2]
Source link